DNA Nanotechnology Speeds Up Discovery of New Drug Candidates
Nov 5, 2026
A high-throughput drug screening platform uses DNA nanoswitches to identify compounds capable of changing how proteins interact.
Read MoreNew PET Scan Technology Identifies Hidden Myeloma Cells Missed on Conventional Scans
Nov 4, 2026New Standard-of-Care for KRAS G12C-Mutated Advanced NSCLC
Nov 4, 2026Surveillance Mammography Doesn’t Improve Survival in Older Women with Breast Cancer History
Nov 4, 2026Insilico’s AI-Designed Mesothelioma Treatment Shows Early Promise
Nov 4, 2026Ryan Beal: Getting Under Cancer’s Skin
Nov 4, 2026Cervical Cancer Cases and Deaths Increasing, Particularly in Africa
Nov 2, 2026Increased Estrogen Over Lifespan Linked to Healthier Vasculature Later in Life
Nov 5, 2026
Haplotype-Based ASOs Can Bypass Bespoke Rare Disease Drug Design
Nov 5, 2026
Ultrasound Implant Could Allow Real-Time Monitoring of Spinal Cord Injury
Nov 4, 2026
AI Marginally Improves Mortality Prediction from Cardiac MRI
Nov 4, 2026
SuperAgers Offer Window on Alzheimer’s Risk
Nov 4, 2026
Peanut Allergy No Longer Found in 35% of Previously Diagnosed Children
Nov 4, 2026
Informatics
Beyond Detection: Rethinking Radiology in the Age of AI
October 20, 2026While advances in artificial intelligence (AI) are opening up possibilities for how images are interpreted, reported, and acted upon, the challenge for healthcare systems lies…
Riaan’s Therapeutic Odyssey – Chapter 1: The Parents
September 03, 2026Riaan's family embarked on a journey to develop an experimental genetic therapy for his ultra-rare Cockayne syndrome, a condition with no existing treatment and a…
Can AI Agents Help the Right Patients Find the Right Trials?
October 20, 2026Clinical trials are generating increasingly large amounts of data, but companies are under immense pressure to complete trials quickly and under budget. Could agentic artificial…
Highly Multiplexed Droplet Digital PCR for Ultra-Sensitive NSCLC Biomarker Detection in Research Workflows
In this IPM webinar, two experts will discuss the growing role of ddPCR in clinical research and translational oncology.
Surbhi Jain, PhD, MBBS
Staff Scientist
Bio-Rad Laboratories
Prithwish Pal, PhD
Director, Global Product Marketing – Oncology
Bio-Rad Laboratories
Five-Year PHERGain Results Support Chemotherapy-Free Treatment for Some Breast Cancer Patients
Oct 30, 2026Five-year follow-up from the PHERGain trial suggests that selected patients with HER2-positive early breast cancer may avoid chemotherapy without compromising long-term disease control.
Encoded Therapeutics Reports Promising Results for Dravet Gene Therapy
Oct 30, 2026Encoded Therapeutics reports promising early Phase I/II results for its AAV gene therapy developed to treat children with Dravet syndrome, a rare neurodevelopmental disorder characterized…
Single-Nucleus Multi-Omic Profiling Reveals Muscle Genetic Regulation Layer
Oct 29, 2026Population-scale transcriptomics and chromatin accessibility profiling uncover thousands of disease-associated regulatory signals missed by transcriptomic analyses, raising questions about how many therapeutic targets are unknown.
Podcast Series
Behind the Breakthroughs
Join host Jonathan D. Grinstein, PhD, North American Editor for Inside Precision Medicine, as he uncovers the stories behind the pioneers driving the precision medicine revolution.
Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter.
Experimental Lupus Therapy Targets Harmful Immune Cells While Sparing Healthy Ones
Base-Editing Gene Therapy Successfully Targets Inherited Disorder
Cancer’s Genetic Weak Spot Offers New Route to Target WNT Signaling
